Cargando…
The Combined Heterozygosity of Factor V Leiden and G20210A Prothrombin Gene Mutation in a Patient With Venous Thromboembolism
Venous thromboembolism (VTE) is a chronic illness that includes pulmonary embolism (PE) and deep vein thrombosis (DVT), and many risk factors are associated. Anticoagulation therapy remains the cornerstone of venous thromboembolism management, and the duration of anticoagulation depends on the risk...
Autores principales: | Machado, Marcia, Cunha, Marta, Gonçalves, Filipe, Fernandes, Carlos, Cotter, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559759/ https://www.ncbi.nlm.nih.gov/pubmed/37809238 http://dx.doi.org/10.7759/cureus.44835 |
Ejemplares similares
-
Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome
por: Padda, Jaskamal, et al.
Publicado: (2021) -
Direct‐to‐consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
por: Elson, Sarah L., et al.
Publicado: (2020) -
Mutation in the Prothrombin Gene G20210A as a Cause of Cerebral Venous Thrombosis
por: Arroyave, Jorge A., et al.
Publicado: (2012) -
Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
por: Akın, Dilara Fatma, et al.
Publicado: (2012) -
Factor V Leiden G1691A and prothrombin G20210A mutations among Palestinian patients with sickle cell disease
por: Samarah, Fekri, et al.
Publicado: (2018)